• 
  Jean-François Timsit, Julien Baleine, Louis Bernard, Silvia Calvino-Gunther, Michael Darmon, et al.. Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit. Annals of Intensive Care, SpringerOpen, 2020, 10 (1), pp.118. ⟨10.1186/s13613-020-00713-4⟩. ⟨hal-03105706⟩
• 
  Antonio Di Meglio, Gwenn Menvielle, Agnès Dumas, Arnauld Gbenou, Sandrine Pinto, et al.. Body weight and return to work among survivors of early-stage breast cancer. European Society for Medical Oncology, BMJ Journals, 2020, 5 (6), pp.e000908. ⟨10.1136/esmoopen-2020-000908⟩. ⟨hal-03066050⟩
• 
  Catherine Uzan, Chafika Mazouni, Caroline Rossoni, Brigitte de Korvin, Christine Tunon de Lara, et al.. Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions. Annals of Surgical Oncology, Springer Verlag, 2020, ⟨10.1245/s10434-020-09107-z⟩. ⟨hal-03013819⟩
• 
  Hortense Chevalier, Angélique Vienot, Astrid Lièvre, Julien Edeline, Farid El Hajbi, et al.. FOLFIRINOX De-Escalationin Advanced Pancreatic Cancer: A MulticenterReal-LifeStudy. Oncologist, AlphaMed Press, 2020, 25 (11), pp.e1701-e1710. ⟨10.1634/theoncologist.2020-0577⟩. ⟨hal-02958602⟩
• 
  Thomas Brodowicz, Bernadette Liegl-Atzwanger, Emmanuelle Tresch-Bruneel, Sophie Taieb, Andrew Kramar, et al.. Study protocol of regosarc trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase ii trial. BMC Cancer, BioMed Central, 2015, BMC Cancer, 15, ⟨10.1186/s12885-015-1143-y⟩. ⟨hal-02535982⟩
• 
  J. Remon, E. Le Rhun, B. Besse. Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era. Cancer Treatment Reviews, WB Saunders, 2017, 53, pp.128-137. ⟨10.1016/j.ctrv.2016.12.006⟩. ⟨inserm-02940527⟩
• 
  A.V. Tallet, F. Dhermain, E. Le Rhun, G. Noël, Y.M. Kirova. Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy. Annals of Oncology, Elsevier, 2017, 28 (12), pp.2962-2976. ⟨10.1093/annonc/mdx408⟩. ⟨inserm-02940523⟩
• 
  Fabien Vidal, Paul Guerby, Mathieu Luyckx, Pascale Haddad, Eberhard Stoeckle, et al.. Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?. PLoS ONE, Public Library of Science, 2016, 11 (1), pp.e0147787. ⟨10.1371/journal.pone.0147787⟩. ⟨inserm-02940269⟩
• 
  Paula Rios, Helene Bauer, Gudrun Schleiermacher, Claudia Pasqualini, Cecile Boulanger, et al.. Environmental exposures related to parental habits in the perinatal period and the risk of Wilms' tumor in children. Cancer Epidemiology, Elsevier, 2020, 66, pp.101706. ⟨10.1016/j.canep.2020.101706⟩. ⟨hal-02887224⟩
• 
  Derek Dinart, Julien Fraisse, Diego Tosi, Audrey Mauguen, Célia Touraine, et al.. GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials. BMC Medical Informatics and Decision Making, BioMed Central, 2020, 20 (1), ⟨10.1186/s12911-020-01149-3⟩. ⟨hal-02889984⟩
• 
  Fatima Tensaouti, Anne Ducassou, Leonor Chaltiel, Stéphanie Bolle, Jean Louis Habrand, et al.. Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma. Frontiers in Oncology, Frontiers, 2019, 9, pp.531. ⟨10.3389/fonc.2019.00531⟩. ⟨hal-02478956⟩
• 
  J.-Y. Blay, C. Honore, E. Stoeckle, P. Méeus, M. Jafari, et al.. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Annals of Oncology, Elsevier, 2019, Annals of oncology official journal of the European Society for Medical Oncology, 30 (7), pp.1143-1153. ⟨10.1093/annonc/mdz124⟩. ⟨hal-02509515⟩
• 
  Emmanuelle Bompas, Loïc Campion, Antoine Italiano, Axel Le Cesne, Christine Chevreau, et al.. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study. Cancer Medicine, Wiley, 2018, Cancer medicine, 7 (8), pp.4023-4035. ⟨10.1002/cam4.1374⟩. ⟨hal-01978221⟩
• 
  Vincent Berry, Laurent Basson, Emilie Bogart, Olivier Mir, Jean-Yves Blay, et al.. Regosarc: regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-a quality-adjusted time without symptoms of progression or toxicity analysis. Cancer, Wiley, 2017, Cancer, 123, pp.2294-2302. ⟨10.1002/cncr.30661⟩. ⟨hal-02638646⟩
• 
  Loic Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, Emmanuelle Bompas, Yves Toiron, et al.. Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO). Oncotarget, Impact journals, 2016, Oncotarget, 7 (45), pp.73984-73994. ⟨10.18632/oncotarget.12172⟩. ⟨hal-01453300⟩
• 
  Pauline Rochefort, Antoine Italiano, Valérie Laurence, Nicolas Penel, Audrey Lardy-Cleaud, et al.. A retrospective multicentric study of ewing sarcoma family of tumors in patients older than 50: management and outcome. Scientific Reports, Nature Publishing Group, 2017, Scientific reports, 7, ⟨10.1038/s41598-017-17733-z⟩. ⟨hal-02613645⟩
• 
  Gilles Houvenaeghel, Eric Lambaudie, Jean-Marc Classe, Chafika Mazouni, Sylvia Giard, et al.. Lymph node positivity in different early breast carcinoma phenotypes: a predictive model. BMC Cancer, BioMed Central, 2019, 19 (1), pp.45. ⟨10.1186/s12885-018-5227-3⟩. ⟨hal-01983749⟩
• 
  Sheraz Markar, Caroline Gronnier, Arnaud Pasquer, Alain Duhamel, Hélène Behal, et al.. Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy. Annals of Surgical Oncology, Springer Verlag, 2017, 24 (13), pp.3911-3920. ⟨10.1245/s10434-017-6088-8⟩. ⟨hal-01892109⟩
• 
  Arnaud Jannin, Benjamin Hennart, Antoine Adenis, Bruno Chauffert, Nicolas Penel. Life-Threatening Irinotecan-Induced Toxicity in an Adult Patient with Alveolar Rhabdomyosarcoma: The Role of a UGT1A1 Polymorphism. Case Reports in Oncological Medicine, Hindawi, 2017, Case reports in oncological medicine, 2017, pp.2683478. ⟨10.1155/2017/2683478⟩. ⟨hal-02365581⟩
• 
  Elodie Girard, Séverine Eon‐marchais, Robert Olaso, Anne‐laure Renault, Francesca Damiola, et al.. Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing. International Journal of Cancer, Wiley, 2019, 144 (8), pp.1962-1974. ⟨10.1002/ijc.31921⟩. ⟨inserm-02438452⟩

70

156